RSSShareTwitterYouTube

Archive for ‘MS Center News

Jul 31 2022 Insights on Multiple Sclerosis in India

Multiple sclerosis lecturers including Dr. Barry Singer being honored at the Madras Medical College in Chennai, India.

The true prevalence of multiple sclerosis in India is unknown, but a new national registry should hopefully provide insights. During my visit to AIIMS (All India Institute of Medical Sciences) in Delhi, Professor Padma Srivastava shared with me that over 1000 MS patients have been entered into the registry so far through a network of neurologists around India. Multiple sclerosis is being diagnosed more readily due increasing access to well-trained neurologists and widespread availability of relatively low-cost MRI imaging.

It was my honor to be invited to lecture at government hospitals to share the United States changes in MS care including early use of high efficacy treatment for appropriate patients. Special thanks to Professor Neera Chaudhary at Safdarjung Hospital in Delhi and Professor R. Lakshmi Narasimhan at Madras Medical College in Chennai and their department faculty for sharing their insights in MS care of Indian patients. In addition, I learned about the high rates of neuromyelitis optica in India similar to many other Asian countries.

Awareness of multiple sclerosis in India is critical for earlier diagnosis and treatment. Monoclonal antibody and generic oral disease-modifying therapies are available, but health inequalities still exist. In this era of numerous treatment options, the prognosis for someone living with MS is much more favorable than prior generations. In India, the stigma of being diagnosed with MS often results in young individuals not being able to marry and have families. Strong advocacy efforts will hopefully lead to change and improved quality of life for those living with MS in India.

Aug 29 2019 Save the Date: Annual MS Breakthrough Program Oct. 22, 2019

Join us for a free educational evening at Missouri Baptist Medical Center for The MS Center for Innovations in Care annual “MS Breakthroughs” program on Oct 22, 2019.  The latest groundbreaking global research including treatment updates will be presented.  Future developments to better monitor MS disease activity in patients will be shared.  Myelin-repair strategies will also be highlighted.

Representatives of the Multiple Sclerosis Association of America, National MS Society, Missouri Baptist Therapy Services and other MS care partners will be present.

Formal presentation will be from 6-7:30 PM followed by a 30 minute question and answer session.  RSVP information coming…

Oct 9 2018 You’re Invited! 2018 MS Breakthroughs Program December 4


JOIN US!! December 4, 2018 from 6:30 PM to 8:30 PM.  Find out the latest in multiple sclerosis advancements after the largest global MS meeting called ECTRIMS which is Oct 10-12, 2018 in Berlin this year.  Barry Singer, MD, Mark Tullman, MD, Barbara Green MD and Melanie Huff NP-C from The MS Center for Innovations in Care will present the most promising and impactful results.  New information on multiple sclerosis treatment and myelin repair will be reviewed.  Free program.  RSVP at 314-996-LIFE or 1-800-392-0936.

The program will be on the CAMPUS of MISSOURI BAPTIST MEDICAL CENTER in the Clinical Learning Institute which is conveniently above the main garage next to the main entrance of the hospital (and in the same building at the Goldfarb School of Nursing).

Jul 14 2018 We’ve Moved! New Center Opens!

The MS Center for Innovations in Care has moved from the 2nd floor of Building B to our brand new space on the FIRST FLOOR  of Building B, Suite 105 on the campus of Missouri Baptist Medical Center. The Center is now conveniently located across the hall from the outpatient lab and next door to the new MS Infusion Center, the region’s only MS-specific infusion center.  With double the square feet, the new center features 10 large exam rooms with accessible exam tables, open nursing stations and clinical research space.  The Center’s staff includes 3 highly-experienced MS specialists,  a MS-certified nurse practitioner, 2 MS nurses, a research coordinator and 8 other support staff including medical assistants.  Our phone number and fax number have not changed.

May 18 2018 Upcoming Program: Understanding MS Progression

The Multiple Sclerosis Association of America (MSAA) invites you to a free educational program on:

Understanding MS Progression: The Importance of Treatment Adherence

Presenter: Barry Singer, MD, Director of The MS Center for Innovations in Care at Missouri Baptist Medical Center

Tuesday June 19 2018 Registration 6:00-6:30 PM, Program 6:30 PM to 8:00 PM

Hilton St. Louis Frontenac, 1335 S. Lindbergh Blvd., St. Louis, MO 63131

Register by Wednesday June 13:  1-800-532-7667, ext. 188 or online at support.mymsaa.org/stlouis

Dec 1 2017 Dr. Barbara Green joins The MS Center for Innovations in Care at Missouri Baptist

We are extremely pleased to announce that Dr. Barbara Green will be joining our center  February 15, 2018.  Dr. Green is a true leader in multiple sclerosis with extensive experience in treating patients with multiple sclerosis including as a long-standing director of a multiple sclerosis center in St. Louis.  She is passionate about superb MS patient care.  As a committed advocate of those living with multiple sclerosis,  Dr. Green has served as chair of the clinical advisory committee for the Gateway Chapter of the National Multiple Sclerosis Society.

Sep 4 2017 Join Us! November 14 MS Breakthroughs Program

SAVE THE DATE!! November 14, 2017 from 6:30 PM to 8:30 PM.  Want the most cutting edge news after the largest global MS meeting called ECTRIMS in Paris?  Barry Singer, MD and Mark Tullman, MD from The MS Center for Innovations in Care will present the most promising and impactful results.  New information on multiple sclerosis treatment and myelin repair will be reviewed.  RSVP at 314-996-LIFE.

This year the program will be on the CAMPUS of MISSOURI BAPTIST MEDICAL CENTER in the Clinical Learning Institute which is conveniently above the main garage next to the main entrance of the hospital (and in the same building at the Goldfarb School of Nursing).

May 29 2017 Team MoBap at Walk MS

Team MoBap 2017

Singer Tullman Planetarium Large EditDynamic Duo

Dr. Singer and Dr. Tullman co-chaired Walk MS this April to raise funds for the National Multiple Sclerosis Society (NMSS).  The funding is critical for new multiple sclerosis research to stop disease progression, restore function, and end MS forever.  Team MoBap was back in force to support NMSS and The MS Center for Innovations in Care in their mission to improve the lives of those living with multiple sclerosis.

Singer St. CharlesTullman Forest Park

Sep 11 2016 Join us October 6, 2016 for MS Breakthroughs Program

You’re invited to our free annual program to hear about the latest in multiple sclerosis treatments including new exciting results in progressive disease.  Groundbreaking research from the world’s largest annual international MS conference in mid September will be presented.  An array of topics will be addressed including bone marrow transplant, stem cells and myelin repair.  Question and answer session will follow.  Light refreshments will be served.

Speakers:  Barry Singer, MD; Mark Tullman, MD; Melanie Huff, BSN, RN.

THURSDAY  October 6, 2016  6:30 to 8:30 PM,  St. Louis Frontenac Hilton, 1335 South Lindbergh

REGISTER: 314-996-LIFE (314-996-5433) or 800-392-0936.

MS Program Flyer

May 14 2016 Scientific Advancements: Center News

IMG_0024Barry Singer, MD, our center’s director, continues to work hard to further our understanding of multiple sclerosis and advance treatment.  He presented scientific posters at the Academy of Neurology Meeting in Vancouver in April 2016.   Topics were the efficacy of using Lemtrada (alemtuzumab) in patients with highly active multiple sclerosis and rapid  benefits of Gilenya (fingolimod) in relapsing forms of multiple sclerosis.

Dr. Singer also just published a chapter in Seminars in Neurology on FDA-approved and future monoclonal antibody treatments for multiple sclerosis.  Tysabri (natalizumab) and Lemtrada (alemtuzumab) are currently available.  Hopefully, both Ocrevus (ocrelizumab) and Zinbryta (daclizumab) will be available within the year.  His chapter also covers remyelination antibodies being studied in clinical trials including opicinumab (Anti-LINGO-1) and rHIgM22.

In addition,  Dr. Singer was extremely pleased to join the Board of Directors for the Multiple Sclerosis Association of America.  As a global patient advocate, this position will allow him to further press for options for those living with multiple sclerosis.